Syncom Formulations (India) Operational Benchmarking
₹23.22-1.48%close, 9 Oct 2026
- Market cap
- ₹2,183 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹16.72 – ₹31.35
Syncom Formulations (India) compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Syncom Formulations (India) sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Syncom Formulations (India) Limited | ₹23.22 | 22.5 | 2,183 | 1.2% | 546 | 14.5% |
| Median (1 Cos) | ₹23.22 | 22.5 | 2,183 | 1.2% | 546 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Syngene International Limited operational benchmarking
- Suven Life Sciences Limited operational benchmarking
- Tatva Chintan Pharma Chem Limited operational benchmarking
- Suraksha Diagnostic Limited operational benchmarking
- Themis Medicare Limited operational benchmarking
- Supriya Lifescience Limited operational benchmarking
Trade Syncom Formulations (India) With ATS
Track SYNCOMF live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.